These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17098619)
1. Infusion services in the gastroenterology practice. Ancowitz B; Shah SA Gastrointest Endosc Clin N Am; 2006 Oct; 16(4):727-42. PubMed ID: 17098619 [TBL] [Abstract][Full Text] [Related]
2. The practice of gastroenterology: evolution versus intelligent design. Brill JV; Chapman FJ; Dahl J Gastrointest Endosc Clin N Am; 2006 Oct; 16(4):623-41. PubMed ID: 17098611 [TBL] [Abstract][Full Text] [Related]
3. The nonphysician provider in the gastroenterology practice. Wagonfeld JB; Murphy RF Gastrointest Endosc Clin N Am; 2006 Oct; 16(4):719-25. PubMed ID: 17098618 [TBL] [Abstract][Full Text] [Related]
4. The ambulatory endoscopy center (AEC): what it can do for your gastroenterology practice. Frakes JT Gastrointest Endosc Clin N Am; 2006 Oct; 16(4):687-94. PubMed ID: 17098615 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the drug treatment regimens for inflammatory bowel disease. Brock EM; Zabihollah M Expert Opin Pharmacother; 1999 Nov; 1(1):15-8. PubMed ID: 11249558 [No Abstract] [Full Text] [Related]
6. Gastroenterology practice in 2006: challenges and opportunities. Ganz RA Gastrointest Endosc Clin N Am; 2006 Oct; 16(4):611-21. PubMed ID: 17098610 [TBL] [Abstract][Full Text] [Related]
7. Just say no to poorly performing payor contracts. Charkin SE; Baum N J Med Pract Manage; 2008; 24(3):129-34. PubMed ID: 19146079 [TBL] [Abstract][Full Text] [Related]
8. Practical strategies for implementing integrative medicine in a primary care setting. Goldman E J Med Pract Manage; 2008; 24(2):97-101. PubMed ID: 19174969 [TBL] [Abstract][Full Text] [Related]
9. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease. Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632 [TBL] [Abstract][Full Text] [Related]
11. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting. Ollendorf DA; Lidsky L Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530 [TBL] [Abstract][Full Text] [Related]
12. Marketing the gastrointestinal practice: strategic considerations. Berkowitz EN Gastrointest Endosc Clin N Am; 2006 Oct; 16(4):657-69. PubMed ID: 17098613 [TBL] [Abstract][Full Text] [Related]
13. Friendly alliances between gastroenterologists and hospitals. Becker S; Moore EK; Mikula AV Am J Gastroenterol; 2007 Nov; 102(11):2367-70. PubMed ID: 17958754 [No Abstract] [Full Text] [Related]
14. Economics of the use of biologics in the treatment of inflammatory bowel disease. Cohen RD; Thomas T Gastroenterol Clin North Am; 2006 Dec; 35(4):867-82. PubMed ID: 17129818 [TBL] [Abstract][Full Text] [Related]
15. Infliximab use in luminal Crohn's disease. Richter JA; Bickston SJ Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813 [TBL] [Abstract][Full Text] [Related]
16. Incorporating quality measurement and improvement into a gastroenterology practice. Pike IM; Vicari J Am J Gastroenterol; 2010 Feb; 105(2):252-4. PubMed ID: 20139870 [No Abstract] [Full Text] [Related]
18. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Reddy JG; Loftus EV Gastroenterol Clin North Am; 2006 Dec; 35(4):837-55. PubMed ID: 17129816 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease surgery in the biologic therapy era. Strong SA Curr Opin Gastroenterol; 2012 Jul; 28(4):349-53. PubMed ID: 22678452 [TBL] [Abstract][Full Text] [Related]
20. Infusion reactions and their management. Mayer L; Young Y Gastroenterol Clin North Am; 2006 Dec; 35(4):857-66. PubMed ID: 17129817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]